Israel is reportedly preparing strike targets against Iranian infrastructure, a move that comes just as a fragile, three-week ceasefire extension between Israel and Hezbollah takes effect.
Back
Israel is reportedly preparing strike targets against Iranian infrastructure, a move that comes just as a fragile, three-week ceasefire extension between Israel and Hezbollah takes effect.

Israel has reportedly identified key infrastructure targets within Iran for potential strikes should hostilities resume, signaling a readiness to escalate even as a US-brokered ceasefire with Hezbollah is extended by three weeks. The move, reported by Israeli media citing defense sources, underscores the persistent risk of a wider conflict, which markets fear could disrupt the 21% of global oil trade passing through the Strait of Hormuz.
The new ceasefire follows the first direct diplomatic talks in decades between Israel and Lebanon, which President Donald Trump said went "very well." Despite the progress, the underlying tensions with Iran remain the primary obstacle. "The obstacle to peace and normalization between the countries is one: Hezbollah," Israeli Foreign Minister Gideon Saar said, describing Lebanon as a "failed state" under "Iranian occupation." The talks in Washington aim to formalize peace, but Hezbollah, which is not a participant, has stated it will not abide by any agreements.
The recent war in Lebanon, which has killed around 2,300 people and displaced over one million, began after Hezbollah fired rockets into Israel just two days after the US and Israel launched attacks on Iran. The fragile ceasefire has already seen multiple violations. A direct conflict between Israel and Iran would likely trigger a sharp "risk-off" move in global markets, with analysts predicting a flight to safe-haven assets like the US dollar and gold, and a broad sell-off in equities.
The durability of any de-escalation efforts remains questionable, largely due to Israeli Prime Minister Benjamin Netanyahu's long-standing hardline stance on Iran. His consistent opposition, which was instrumental in the US withdrawal from the 2015 Joint Comprehensive Plan of Action (JCPOA) nuclear deal, suggests that any agreement perceived as falling short of eliminating Iran's nuclear capabilities will face significant political and strategic challenges, making a lasting peace difficult to achieve.
Netanyahu’s opposition to the JCPOA was public and confrontational, culminating in a 2015 address to the US Congress where he argued the deal would "pave Iran's path to the bomb." While the Obama administration pushed the deal through, Netanyahu’s resistance ensured it never gained bipartisan support in the US, planting the seeds for its eventual reversal. Under President Trump, this opposition found a more receptive audience. A sustained campaign, including a 2018 presentation of alleged secret Iranian nuclear documents, provided the narrative for Trump to withdraw the US from the JCPOA shortly thereafter.
This history forms the critical backdrop to the current tensions. What former President Obama constructed through negotiation, Netanyahu helped unravel through persistence. The subsequent "maximum pressure" campaign of sanctions aligned perfectly with Israel's strategic goals. Now, as diplomatic channels are tentatively explored again, with Pakistan reportedly mediating between the US and Iran, the fundamental dilemma remains. EU foreign policy chief Kaja Kallas warned that current talks risk forging a "weaker" agreement than the original JCPOA, which may not be acceptable to Israel.
For markets, this creates a structural instability. Any diplomatic progress is viewed through the lens of whether it can survive the inevitable scrutiny from an Israeli leadership that has consistently rejected partial or temporary solutions. As long as Netanyahu's interpretation of Israel's security needs sets the benchmark, the threshold for an acceptable deal remains extraordinarily high, and the risk of a military confrontation that could roil global energy supplies and financial markets remains acute.
This article is for informational purposes only and does not constitute investment advice.